BUZZ — Johnson & Johnson slips as weak device sales clouds earnings beat
(Updates) * Shares of Johnson & Johnson fall 4.4% to $252.38 * JNJ's Q3 MedTech sales rise 2.5% to $8.6 bln, but misses analysts' est of $8.71 bln - LSEG * Overall, Q3 adj EPS of $2.59 beats est of $2.54, and sales of $25.4 bln beat est of $25.28 bln - LSEG * "While the results overall are generally inline with expecta